- Home
- ONBPO vs HUMAW Comparison
ONBPO vs HUMAW Comparison
Compare ONBPO & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONBPO
- HUMAW
- Stock Information
- Founded
- ONBPO N/A
- HUMAW 2004
- Country
- ONBPO United States
- HUMAW United States
- Employees
- ONBPO 4066
- HUMAW 185
- Industry
- ONBPO Major Banks
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- ONBPO Finance
- HUMAW Health Care
- Exchange
- ONBPO Nasdaq
- HUMAW Nasdaq
- Market Cap
- ONBPO N/A
- HUMAW N/A
- IPO Year
- ONBPO N/A
- HUMAW N/A
- Fundamental
- Price
- ONBPO $24.79
- HUMAW $0.34
- Analyst Decision
- ONBPO
- HUMAW
- Analyst Count
- ONBPO 0
- HUMAW 0
- Target Price
- ONBPO N/A
- HUMAW N/A
- AVG Volume (30 Days)
- ONBPO N/A
- HUMAW 14.2K
- Earning Date
- ONBPO N/A
- HUMAW 03-21-2025
- Dividend Yield
- ONBPO N/A
- HUMAW N/A
- EPS Growth
- ONBPO N/A
- HUMAW N/A
- EPS
- ONBPO N/A
- HUMAW N/A
- Revenue
- ONBPO N/A
- HUMAW N/A
- Revenue This Year
- ONBPO N/A
- HUMAW N/A
- Revenue Next Year
- ONBPO N/A
- HUMAW N/A
- P/E Ratio
- ONBPO N/A
- HUMAW N/A
- Revenue Growth
- ONBPO N/A
- HUMAW N/A
- 52 Week Low
- ONBPO N/A
- HUMAW $1.18
- 52 Week High
- ONBPO N/A
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- ONBPO 49.17
- HUMAW N/A
- Support Level
- ONBPO $24.44
- HUMAW N/A
- Resistance Level
- ONBPO $24.94
- HUMAW N/A
- Average True Range (ATR)
- ONBPO 0.34
- HUMAW 0.00
- MACD
- ONBPO 0.01
- HUMAW 0.00
- Stochastic Oscillator
- ONBPO 47.30
- HUMAW 0.00
About ONBPO Old National Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of Series C Preferred Stock
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.